Ashwagandha can help fight COVID-19, claims study

May 18, 2020 19:13

Ayurvedic herb Ashwagandha can be an effective therapeutic and preventive drug against the COVID-19 infection, a collaborative research by IIT-Delhi and Japan's National Institute of Advanced Industrial Science and Technology has found.

The natural compounds from Ashwagandha and Propolis have the potential to be an effective novel coronavirus preventive drug, according to the research team.

"The researchers targeted the main SARS-CoV-2's enzyme for splitting proteins, known as the main protease (Mpro), that plays a key role in mediating viral replication. This is an attractive drug target for this virus, and as humans don't naturally have this enzyme, compounds that target Mpro are likely to have low toxicity," said D Sundar, head of the Delhi Indian Institute of Technology's Biotechnology department.

"The findings may not only connect to save time and cost required for screening for anti-COVID-19 drugs, but may also offer some preventive and therapeutic value for the management of fatal COVID-19 pandemic, and hence, warrant prioritized validation in the laboratory and clinical tests," he said.

The drug's development may take some time, and in the current scenario, these natural resources -- Ashwagandha and Propolis -- can offer some preventive or even therapeutic value, according to Sundar.

He said that "although these are easily available and affordable, one has to be cautious about the content of bioactive ingredients. CAPE, while is a major component of propolis, its amount and stability are critical factors that could be managed by generating its complex with cyclodextrins".

"Withanone, on the other hand, varies with geography, parts and size of the Ashwagandha plant. So, in order to acquire or appreciate particular effects, we must use the right and quality-controlled resource and extracts," Sundar said.

The government has also initiated a study on whether Ashwagandha can be an alternative to anti-malarial drug Hydroxychloroquine (HCQ) as a potential COVID-19 preventive.

The study is being carried out by a group of scientists and researchers from the Ministry of AYUSH, the Ministry of Health and Family Welfare, the University Grants Commission and the Indian Council of Medical Research.

"While new line of drug and vaccine development have been initiated worldwide, in the current scenario of high infected numbers, severity of the disease and high morbidity, repurposing of the existing drugs are heavily explored by recruiting integrative genomics and bioinformatics research tools," Sundar said. -- PTI

« Back to LIVE

TOP STORIES

Kejriwal stopped taking insulin before his arrest: Tihar officials

The Delhi minister also claimed that Kejriwal used to take 50 units of insulin daily before he was sent to jail.

Be present or 'necessary order'...: Court to Pragya Thakur

On April 8, relying on a compliance report submitted by National Investigation Agency on Thakur's medical condition, Special NIA Judge A K Lahoti granted her exemption from personal appearance but had asked the Bhopal Lok Sabha MP to...

Odisha boat capsize toll rises to 8, search op ends

The incident took place when around 50 passengers hailing from Kharsia area in the neighbouring Chhattisgarh were returning in the boat after visiting a temple in Patharseni Kuda in Odisha's Bargarh district.

Unstoppable Duplantis breaks World record for 8th time!

The Swede broke his own pole vault world record with a 6.24 metres effort in the first Diamond League meeting.

Vinesh, Reetika, Anshu secure Paris Olympics quotas

Vinesh Phogat locked Paris Olympics quota in the women's 50kg category, reaching the final at the Asian Olympic Qualifier without conceding a single point.